Use of intrauterine devices in nulliparous women

Contraception. 2017 Jun;95(6):529-537. doi: 10.1016/j.contraception.2016.08.011. Epub 2016 Aug 31.

Abstract

Five intrauterine devices (IUDs) are available in the United States: four levonorgestrel-releasing intrauterine systems (two containing 52 mg, one containing 19.5 mg and one containing 13.5 mg) and one copper-bearing device (Copper T 380A). All IUDs have very low typical-use failure rates and high acceptability ratings, yet they are used by a minority of women, with nulliparous women less likely to do so than parous women. The objective of this clinical review is to give evidence-based recommendations for the use of IUDs in nulliparous women. Intrauterine devices are safe and effective for the majority of women including those who are nulliparous, and should be routinely included in the contraception options offered to them.

Keywords: IUD; IUS; Intrauterine contraception; Intrauterine device; Intrauterine system; Nulliparous.

Publication types

  • Practice Guideline

MeSH terms

  • Adolescent
  • Adult
  • Contraception / methods*
  • Contraceptive Agents, Female
  • Equipment Failure
  • Female
  • Fertility
  • Humans
  • Intrauterine Devices* / adverse effects
  • Intrauterine Devices, Copper / adverse effects
  • Intrauterine Devices, Medicated / adverse effects
  • Levonorgestrel / administration & dosage
  • Levonorgestrel / adverse effects
  • Parity*
  • Patient Satisfaction
  • Pregnancy
  • Risk Factors
  • United States
  • Young Adult

Substances

  • Contraceptive Agents, Female
  • Levonorgestrel